The Effects of Exercise on Breast Cancer
- 2 days ago
- 11 min read
Breast cancer is the most commonly diagnosed cancer in women worldwide, with over 2.3 million new cases each year, and remains a leading cause of cancer-related death. Despite significant advances in screening, molecular classification, and treatment strategies, its global burden continues to increase, highlighting the need for additional approaches beyond conventional therapies.
In recent years, attention has shifted toward modifiable lifestyle factors, particularly physical activity, as important contributors to both cancer prevention and patient outcomes. A strong body of evidence shows that regular exercise is associated with reduced breast cancer risk, lower recurrence rates, and improved survival. These benefits extend across different populations and appear to act independently of traditional risk factors such as body mass index.
Unlike pharmacological treatments that typically target a single pathway, exercise exerts system-wide effects, influencing hormonal balance, metabolism, immune function, and inflammation—all of which play key roles in cancer development and progression. Emerging data also suggest that exercise may directly modify the tumor microenvironment, enhancing anti-tumor immune responses.
This article explores the role of exercise in breast cancer by first providing a brief overview of the disease, followed by a detailed analysis of the biological mechanisms and clinical effects of physical activity across the cancer continuum.
Breast Cancer: A Brief Scientific Overview
Epidemiology and Global Impact
Breast cancer is the most frequently diagnosed malignancy in women worldwide and represents a major contributor to global cancer burden. Recent data estimate more than 2.3 million new cases annually, making it the leading cancer in women across both developed and developing regions. In addition to its high incidence, breast cancer remains one of the primary causes of cancer-related mortality, with hundreds of thousands of deaths each year.
The distribution of breast cancer varies significantly across regions. While incidence rates are higher in high-income countries, mortality rates are disproportionately elevated in low- and middle-income regions due to limited access to screening and treatment. Survival is strongly dependent on early detection and advances in therapy, with significantly better outcomes observed in localized disease compared to advanced stages.
Pathophysiology and Carcinogenesis
Breast cancer develops through a complex, multistep process driven by genetic mutations and environmental influences. Like other malignancies, it is characterized by key biological capabilities, including uncontrolled cell proliferation, resistance to cell death, sustained angiogenesis, and the ability to invade and metastasize.
At the molecular level, breast cancer is highly heterogeneous. Based on gene expression profiles, it can be classified into major subtypes such as:
Luminal A
Luminal B
HER2-enriched
Basal-like (triple-negative)
These subtypes differ in their biological behavior, prognosis, and response to therapy, making molecular classification essential for personalized treatment strategies .
Risk Factors
The development of breast cancer is influenced by a combination of non-modifiable and modifiable risk factors.
Non-modifiable factors
Age: Risk increases significantly after 50 years
Genetic predisposition: Mutations in genes such as BRCA1 and BRCA2
Hormonal exposure: Lifetime exposure to estrogen and progesterone
Family history of breast or ovarian cancer
These factors largely determine baseline susceptibility and cannot be altered.
Modifiable factors
Obesity and increased body fat
Alcohol consumption
Smoking
Dietary patterns
Physical inactivity
Among these, physical inactivity stands out as a critical and potentially reversible risk factor, linking lifestyle directly to breast cancer development.
This multifactorial nature of breast cancer highlights an important concept: while genetic and biological factors set the foundation, lifestyle-related influences play a substantial role in modulating risk and disease progression. This provides the scientific basis for exploring exercise not only as prevention, but as a meaningful component of cancer management.
